Agenda

DOWNLOAD THE 2021 CONFERENCE AGENDA

CLINICAL

GENERAL/PRACTICE OPERATIONS

THURSDAY, APRIL 8, 2021

8:30 - 8:50 AM EDT

Conference Opening & Welcome From the Co-Chairs

  • Stephen "Fred" Divers, MD, Medical Oncologist, Genesis Cancer Center & American Oncology Network
  • Debra Patt, MD, PhD, MBA, Vice President, Texas Oncology & The US Oncology Network
  • Jeffrey M. Patton, MD, Chief Executive Officer, OneOncology, Chairman of the Board, Tennessee Oncology
  • Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants
  • Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders & OneOncology
  • Jeffrey Vacirca, MD, FACP, Chief Executive Officer, New York Cancer & Blood Specialists & OneOncology

8:55 - 9:35 AM EDT

Learnings From COVID-19: How Cancer Care has Innovated & Evolved

  • Lucio Gordan, MD, Managing Physician, President, Florida Cancer Specialists & Research Institute
  • James Perry, MD, Chief Medical Officer, Alliance Cancer Specialists
  • Jennifer Pichoske, MS, AOCNP, Chief Clinical Officer, Hematology-Oncology Associates of Central New York
  • Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders & OneOncology, Moderator

9:40 - 10:10 AM EDT

State-of-the-Art Cancer Care in the Community Setting: Immunotherapies, Gene Therapies, Theranostics

  • Tony Abraham, DO, MPA, Director of PET/CT & Theranostics, NY Imaging Specialists
  • David Spigel, MD, Chief Scientific Officer, Sarah Cannon Research Institute, Partner, Tennessee Oncology

10:15 - 10:55 AM EDT

Keynote Speaker: Shining the Light on Hospital Drug Pricing & Markups

  • Aharon "Ronny" Gal, PhD, BSc, Senior Analyst, Bernstein

10:55 - 11:15 AM EDT

Break to Visit the Virtual Exhibit Hall

11:15 - 11:55 AM EDT

How Employers Approach Cancer Care & Benefit Design

  • Robert Baird, Jr., RN, MSA, President, National Cancer Treatment Alliance, Moderator
  • Bret Jackson, President, Economic Alliance of Michigan
  • Ruth Opdycke, PharmD, MS, Principal Advisor, Confidio
  • Candace Shaffer, MS, CWPM, Senior Director, Benefits, Vice President for Human Resources, Purdue University

12:00 - 12:30 PM EDT

Managing New Drugs in Breast Cancer: Therapeutic Opportunities & Challenges

  • Joyce A. O’Shaughnessy, MD, Celebrating Women Chair in Breast Cancer Research, Baylor University Medical Center, Director, Breast Cancer Research Program, Texas Oncology, The US Oncology Network

12:35 - 1:05 PM EDT

Integrating Palliative Care into Community Practice

  • Morvarid "Mo" Rezaie, DO, HMDC, FACOI, Palliative Medicine Physician, The Center for Cancer & Blood Disorders

1:05 - 1:35 PM EDT

Break to Visit the Virtual Exhibit Hall

1:35 - 2:15 PM EDT

Defining Value in Cancer Care: Patient, Physician, & Employer Perspectives

  • Beth A. Curran, Senior Director, Risk Management, Orange County Public Schools
  • Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, Moderator
  • Edward Licitra, MD, PhD, Medical Oncologist, Astera Health Partners
  • Tomi Ramey, CPAN Advocate/Survivor

2:20 - 3:00 PM EDT

A New Model for Cancer Care: Ensuring & Measuring Quality

  • Michael Diaz, MD, Director of Patient Advocacy & Assistant Managing Physician, Florida Cancer Specialists & Research Institute, Immediate Past President, Community Oncology Alliance
  • Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, Moderator
  • Lalan Wilfong, MD, Executive Vice President, Value Based Care & Quality Programs, Texas Oncology, COA Payment Reform Co-Chair

3:05 - 3:35 PM EDT

Providing Behavioral Health in Community Oncology: New Models & Interventions

  • Chris Murray, PhD, Psychotherapist, The Center for Cancer & Blood Disorders

3:40 - 4:20 PM EDT

Evolving World of Biomarker Testing & Therapeutic Strategies: Realizing the Promise of Personalized Medicine

  • Martin Dietrich, MD, PhD, Medical Oncologist, Florida Cancer Specialists, Assistant Professor of Internal Medicine, University of Central Florida Cancer Center
  • Bobby Green, MD, Chief Medical Officer, Flatiron Health, Moderator
  • Geoffrey R. Oxnard, MD, Vice President, Global Medical Lead, Liquid Portfolio at Foundation Medicine
  • Anthony “Nino” Sireci, MD, Vice President, Diagnostics Development & Medical Affairs, Loxo Oncology, Lilly
  • Byeong Yoon, Executive Director, Oncology Global Medical Affairs, Amgen

4:25 - 5:00 PM EDT

Measuring Cancer Patient Experience & Quality: The Now & Future of Patient Tracking

  • Rachel DuPré Brodie, Senior Director, Measurement & Accountability, Purchaser Business Group on Health
  • Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance

FRIDAY, APRIL 9, 2021

8:30 - 8:50 AM EDT

Conference Opening Day Two: Update From the Co-Chairs

  • Stephen "Fred" Divers, MD, Medical Oncologist, Genesis Cancer Center & American Oncology Network
  • Debra Patt, MD, PhD, MBA, Vice President, Texas Oncology & The US Oncology Network
  • Jeffrey M. Patton, MD, Chief Executive Officer, OneOncology, Chairman of the Board, Tennessee Oncology
  • Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants
  • Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders & OneOncology
  • Jeffrey Vacirca, MD, FACP, Chief Executive Officer, New York Cancer & Blood Specialists & OneOncology

8:55 - 9:35 AM EDT

Maximizing Practice Efficiencies & Reducing Costs: What Your Practice can do Tomorrow

  • Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, Moderator
  • Marcus Neubauer, MD, Chief Medical Officer, The US Oncology Network
  • Todd O’Connell, Chief Operating Officer, Chief Financial Officer, New York Cancer & Blood Specialists
  • Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants

9:40 - 10:20 AM EDT

Biosimilars in Cancer Care: Challenges & Opportunities

  • E. Randolph "Randy" Broun, MD, Blood & Marrow Transplant Specialist, OHC (Oncology Hematology Care, Inc.)
  • Sonia Oskouei, PharmD, BCMAS, DPLA, Vice President, Biosimilars, Cardinal Health
  • Kathy Oubre, MS, Chief Operating Officer, Pontchartrain Cancer Center, Moderator
  • Sandeep Parsad, PharmD, MBA, BCOP, Assistant Director of Pharmacy, Hematology/Oncology & Investigational Drug Services, Director, PGY2 Oncology Pharmacy Residency Program, University of Chicago Medicine

10:20 - 10:50 AM EDT

Break to Visit the Virtual Exhibit Hall

10:50 - 11:30 AM EDT

Keynote Speaker: Keep Climbing

  • Sean Swarner, Author, Adventurer, & Cancer Survivor

11:35 AM - 12:15 PM EDT

Legislative Update From Capitol Hill: Cancer Politics & Policy in Washington, D.C.

  • Christian G. Downs, JD, MHA, Executive Director, Association of Community Cancer Centers
  • Ben Jones, Vice President, Government Relations & Public Policy, The US Oncology Network
  • Deborah Kamin, RN, PhD, Vice President, Policy & Advocacy, American Society of Clinical Oncology
  • Rebecca McGrath, Vice President, Government Relations & Public Policy, Cardinal Health
  • Ted Okon, MBA, Executive Director, Community Oncology Alliance, Moderator
  • Brad Tallamy, Senior Director, Government Affairs, AmerisourceBergen

12:20 - 1:00 PM EDT

Overcoming the Latest PBM & Insurer Tactics: Prior Authorizations, White Bagging, Copay Accumulators, & More

  • Jonathan E. Levitt, Esq., Founding Partner, Frier Levitt, LLC
  • Ted Okon, MBA, Executive Director, Community Oncology Alliance, Moderator
  • Rich Ingram, MD, Medical Oncologist, Hematologist, Shenandoah Oncology
  • Stuart Genschaw, MHA, MBA, Chief Executive Officer, Cancer & Hematology Centers of Western Michigan

1:00 - 1:30 PM EDT

Break to Visit the Virtual Exhibit Hall

1:30 - 2:00 PM EDT

New Advances in Lung Cancer Therapies Coming in 2021

  • Alexander Spira, MD, PhD, FACP, Director, Virginia Cancer Specialists Research Institute, US Oncology Research, Assistant Professor of Oncology, Johns Hopkins School of Medicine

2:05 - 2:45 PM EDT

New Coding & Reimbursement Changes in 2021: Best Practices

  • Johnetta Blakely, MD, Executive Director of HEOR, Tennessee Oncology
  • Roberta Buell, MBA, Principal, onPoint Oncology, Inc.
  • Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, Moderator
  • Barbara L. McAneny, MD, FASCO, MACP, Chief Executive Officer, Founding Partner, New Mexico Oncology Hematology Consultants, LTD.

2:50 - 3:20 PM EDT

The Latest in Chronic Lymphocytic Leukemia (CLL) Treatment

  • Jeff Sharman, MD, Director of Research, Williamette Valley Cancer Institute & Research Center, Medical Director of Hematology Research, The US Oncology Network

3:25 - 4:05 PM EDT

Socioeconomic Disparities in Cancer Care: What are the Consequences & Solutions?

  • Nicolas Ferreyros, Director of Communications, Community Oncology Alliance, Moderator
  • Barbara L. McAneny, MD, FASCO, MACP, Chief Executive Officer, Founding Partner, New Mexico Oncology Hematology Consultants, LTD.
  • Kashyap Patel, MD, Chief Executive Officer, Carolina Blood & Cancer Care Associates, President, Community Oncology Alliance
  • Karen Winkfield, MD, PhD, Executive Director, Meharry-Vanderbilt Alliance, Ingram Professor of Cancer Research, Vanderbilt Ingram Cancer Center

4:10 - 4:40 PM EDT

Novel Approaches & Therapies for Gastrointestinal Cancers: Updates from the Field of GI Oncology

  • Johanna Bendell, MD, Chief Development Officer, Director of the GI Cancer Research Program, Sarah Cannon Research Institute

4:45 - 5:00 PM EDT

Conference Wrap-Up: Meeting Observations From the Co-Chairs

  • Stephen "Fred" Divers, MD, Medical Oncologist, Genesis Cancer Center & American Oncology Network
  • Debra Patt, MD, PhD, MBA, Vice President, Texas Oncology & The US Oncology Network
  • Jeffrey M. Patton, MD, Chief Executive Officer, OneOncology, Chairman of the Board, Tennessee Oncology
  • Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants
  • Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders & OneOncology
  • Jeffrey Vacirca, MD, FACP, Chief Executive Officer, New York Cancer & Blood Specialists & OneOncology

* All Sessions take place Eastern Daylight Time (EDT)